Harnessing Institutional Capital to Deliver Housing for Future Talent
Although residential real estate is the world's largest asset class by value, dwarfing commercial estate by some margin, residential is still considered an alternative asset class within the property world.
This is despite houses predating both modern offices and shops by millennia, and having somewhere to live is a fundamental human need.
That said, COVID-19 may have finally moved residential from alternative to mainstream. Despite the global pandemic, house prices rose significantly in pretty much every major economy, while many residential tenants proved better rent payers than a lot of commercial occupiers.
Investor interest in specialised forms of residential such as build-to-rent and student accommodation was growing before coronavirus. Attractive demand/supply dynamics combined with the promise of liability matching income streams that have defensive, counter-cyclical qualities saw institutional investors such as pension funds and insurers making big plays in both sectors.
Investor interest in the living sectors will only grow.
COVID-19 revealed the vulnerability of mainstream property investments such as offices and shopping centers, and likely accelerated the long term trends that were inevitably going to challenge them. In sum: lockdown made most people realise they can work or shop from anywhere.
COVID-19 also shone a spotlight on life sciences, with AstraZeneca and Pfizer now both household names thanks to their vaccine success. While pharmaceutical firms like these require highly specialised buildings typically backed up by a strong operating platform, that hasn't stopped heavyweights such as British Land looking to enter life sciences real estate.